VEGFA and macular retinal edema: Anti-VEGF treatments for macular oedema secondary to RVO resulted in overall positive changes from index VA, with mean VA gains of 11.3–11.8 approximate ETDRS letters (equivalent to 2.3–2.4 lines) at Month 12 and 7.0–8.3 approximate ETDRS letters (equivalent to 1.4–1.7 lines) at Month 60.